Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R41/R42)
Jurisdiction: | Federal |
Incentive Type: | Grant Program |
Industries: | Health And Safety |
Eligible Sector: | Business |
Category: | Financial Incentive |
Time Period: | FY 2015 |
Governing Body: | National Institutes of Health |
What’s it worth?: | Not mentioned |
The Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research program was developed to provided funding for Small Business Technology Transfer grant applications to enable the research of structure and/or function of the brain to be conducted. NIMH prioritizes technologies and approaches aiming at known receptor subtypes and orphan receptors. Ideal studies include but are not excluded to:
- New technologies and approaches to further explain GPCRs function.
- Specific applications designed to define GPCRs and molecules structural relationships
- Studies addressing a variety of mental health disorders including:
– Schizophrenia
– Depression
– Bipolar disorder
– Attention deficit hyperactivity disorder
– Anxiety disorders
– Eating disorders
– Tourette’s syndrome
– Obsessive compulsive disorder
– Autism spectrum disorders
– HIV-associated neurocognitive disorders
– Etc.
Grant awards typically do not exceed $1,000,000 per project and possible 50% increase upon Congress approval. Applicants are encourage to contact the NIH program officials before proposing anything in excess of the guidelines.
Applications must be complete and received before the deadline.